不同剂量的猪瘟活疫苗单次免疫效果评价及疫苗存留试验

用1 200 RID、6 000 RID和24 000 RID 3种不同剂量的猪瘟活疫苗单次免疫9头30日龄的断奶仔猪,检测试验猪的抗体消长和疫苗毒核酸在猪体内的存留时间,并用6头猪进行攻毒保护试验.结果表明:不同免疫剂量的试验猪其抗体水平的动态变化没有显著差异,免疫后21 d试验猪的猪瘟抗体均成阳性,63 d后至578 d猪瘟抗体阻断率仍然高于85％,应用荧光定量RT-PCR技术检测,猪瘟疫苗毒核酸在猪血液和扁桃体中的检出时间分别达28 d和42 d;免疫后370 d进行猪瘟强毒攻击后,免疫猪没有出现明显的临床症状,存活且不带毒.本研究证实,没有其他疫病和母源抗体的仔猪单次接种合理剂量的猪瘟活疫苗就能产生坚强的保护力,提出加强种猪场各种病原监测,淘汰病原阳性种猪,净化种猪群对提高猪瘟疫苗免疫效果,最终控制猪瘟具有重要意义.     

黄芪多糖对接种NDⅣ雏鸡红细胞免疫功能的影响

以50日龄内健康海兰白雏鸡为研究对象,将黄芪多糖（APS）按0 mg/只、5 mg/只和10 mg/只经滴鼻点眼、肌肉注射等方式分别与鸡NDⅣ系疫苗同时免疫接种适龄雏鸡。结果表明,雏鸡C3b受体花环率（E-C3bRR）和红细胞C3b受体花环促进率（ERER）显著升高,红细胞免疫复合物花环率（E-ICRR）和红细胞C3b受体花环抑制率（ERIR）则降低,即APS可显著提高雏鸡的红细胞免疫功能,且APS 10 mg/只组效果优于5 mg/只组;对NDⅣ系苗免疫雏鸡来说,以APS 10 mg/只肌肉注射,NDⅣ滴鼻点眼对红细胞免疫功能的增强作用最显著。     

北京动物园圈养绿孔雀新城疫免疫实验研究

通过圈养绿孔雀新城疫免疫实验研究,对疫苗的安全性以及免疫效果进行了评估。单苗实验组结果：低毒活苗LASOTA可以使抗体水平在4LOG2以上的时间持续6个月;灭活油苗可以使抗体水平保持在4LOG2以上8个月。联苗实验组接种LASOTA疫苗同时肌肉注射灭活油苗后,抗体水平保持4LOG2以上15个月,表明圈养绿孔雀宜采用联合疫苗免疫方法。联合疫苗的应用不仅表现在较高抗体水平维持时间较长,低毒活疫苗还有产生黏膜免疫的重要意义。滴鼻或点眼接种LASOTA疫苗,要保证疫苗能够作用于哈氏腺,以激发动物机体产生黏膜免疫。此外免疫接种时机很重要,对该病的预防工作不应在动物机体较高抗体水平的时候进行免疫接种,也不应在动物机体已经失去保护力或隐性感染后盲目接种,应选择绿孔雀在健康无病情况下进行。同时为了有效地控制新城疫,必须加强禽群免疫监测。     

鸡新城疫、禽流感二联灭活疫苗与同类产品的免疫效力比较

将鸡新城疫、禽流感（H9亚型,SY株）二联灭活疫苗与市售同类对照苗分不同剂量皮下注射接种30日龄SPF鸡,免疫后定期采血,分离血清,通过检测血清中ND和AI的HI抗体水平比较各组鸡抗体产生期、抗体高峰及免疫持续期,并进行不同血凝抗原检测HI抗体结果的对比。试验鸡血清样品检测结果显示,免疫鸡抗体产生期为免后2周内,免后8周和5周ND和AI的HI抗体滴度分别达到峰值,抗体至少可持续28周以上,两种灭活苗之间免疫效果基本相当。     

悬浮培养在口蹄疫疫苗中的应用

通过生物反应器中进行BHK21细胞悬浮培养并逐级放大,分别接种口蹄疫OJMS/2000株与Asia 1/JSL株,纯化灭活后制备50批疫苗,结果均符合《口蹄疫O型、亚洲I型二价疫苗（OJMS株＋JSL株）制造及检验规程》（以下称规程）所规定的各项标准,病毒146S抗原含量比转瓶培养提高10倍以上、疫苗的不良反应得到进一步改善。     

禽流感H9亚型SD696株疫苗生产工艺改进试验

分别采用10日龄和12日龄SPF鸡胚增殖禽流感H9亚型SD696株病毒,并改变后孵化温度,将死亡高峰期、最终死亡率、平均单胚收获量、尿囊液血凝价HA、病毒含量EID50进行对比,结果表明用12日龄SPF鸡胚比用10日龄SPF鸡胚增殖禽流感H9亚型SD696株病毒,死亡高峰期推迟12-24 h,最终死亡率、尿囊液的HA和EID50无差异,平均单胚收获量提高了2-3mL。35℃培养比37℃培养鸡胚死亡高峰期延迟、最终死亡率降低、平均单胚收获量提高、尿囊液的血凝价HA及病毒含量EID50偏高。选择12日龄SPF鸡胚,35℃培养温度为生产工艺,既提高疫苗产量,降低成本,又能够提高产品的质量。     

谈对半成品抗原半数感染量判定方法的理解

在兽用生物制品生产中,常用病毒半数感染量（EID50）来表示病毒类疫苗及其半成品抗原的效价,作者以鸡新城疫活疫苗为例,对其半成品抗原及成品EID50的判定方法进行比较分析,加深了对准确表达每毫升半成品抗原病毒含量判定方法的理解。     

猪瘟活疫苗(脾淋源)污染外源性兔出血症病毒的检测与启示

在进行2批猪瘟活疫苗（脾淋源）效力检验时,出现效力检验家兔突然死亡现象,为了查明家兔死亡原因,采用无菌检验、支原体检验、血凝试验、兔体中和试验、酶联免疫吸附试验（ELISA）对疫苗或注苗后死亡家兔肝脏、脾脏混合病料进行了检测。结果显示,疫苗的无菌检验、支原体检验结果均为阴性;疫苗及注射疫苗死亡家兔肝脏、脾脏混合病料具有较低的血凝价,血凝试验结果均为可疑;在兔体中和试验中,中和组家兔2／2健康存活,未中和的疫苗对照组家兔2／2死亡;疫苗及注射疫苗死亡后家兔肝脏、脾脏混合病料的ELISA检测结果均为阳性。检测结果证实疫苗中含有兔出血症病毒（Rabbit Haemorrhagic Disease Virus,RHDV）。猪瘟活疫苗（脾淋源）污染RHDV的现象启示：应该加强猪瘟活疫苗（脾淋源）抗原制备过程的控制;同时有必要对猪瘟活疫苗（脾淋源）质量标准进行修订使之进一步补充完善。     

Vaccination of Poultry Workers: Delivery and Uptake of Seasonal Influenza Immunization

Avian influenza is a highly infectious disease in poultry and although the risk of human infection is low, concerns exist that it could evolve into a new human strain of pandemic potential if reassortment with a human influenza virus occurs. In January 2007, the UK government introduced a programme to vaccinate poultry workers to reduce the potential of such an event. This study evaluates the delivery, uptake and costs of the programme in three counties of England. A questionnaire survey was completed by consultants in public health in all the Primary Care Trusts in Norfolk, Suffolk and Cambridgeshire in May 2007. The delivery of the programme varied between Primary Care Trusts, including being delivered in some cases by clinics in primary care, by general practitioners and occupational health services in others. The uptake of vaccination was low ranging from 7% to 29% at a cost of £29 to £132 per person vaccinated. Vaccination of poultry workers as a public health measure to prevent an influenza pandemic is likely to be ineffective with the level of coverage found in this evaluation in our region.     

A Retrospective Economic Analysis of the Ontario Red Fox Oral Rabies Vaccination Programme

Ontario initiated a red fox (Vulpes vulpes ) oral rabies vaccination (ORV) programme in 1989. This study utilized a benefit‐cost analysis to determine if this ORV programme was economically worthwhile. Between 1979 and 1989, prior to ORV baiting, the average annual human post‐exposure treatments, positive red fox rabies diagnostic tests and indemnity payments for livestock lost to rabies were 2248, 1861 and $246 809, respectively. After baiting, from 1990 to 2000, a 35%, 66% and 41% decrease in post‐exposure treatments, animal rabies tests and indemnity payments was observed, respectively. These reductions were viewed as benefits of the ORV programme, whereas total costs were those associated with ORV baiting. Multiple techniques were used to estimate four different benefit streams and the total estimated benefits ranged from $35 486 316 to $98 413 217. The annual mean ORV programme cost was $6 447 720, with total programme costs of $77 372 637. The average benefit‐cost ratios over the analysis period were .49, 1.06, 1.27 and 1.36, indicating overall programme efficiency in three of the four conservative scenarios.